Concentrix is trading at $22.65, down 9.16%, in pre-market on September 30 after Q3 revenue missed forecasts. - Its September 29 report showed adjusted EPS beat, but revenue was $2.45 billion versus the $2.48 billion forecast; coverage cited a sharp after-hours decline. - Revenue fell 1.2% year over year; the quarter included a $1.05 billion non-cash goodwill impairment tied primarily to the company’s stock trading range and market capitalization. - FY 2026 non-GAAP EPS guidance is $10.97–$11.09.